Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

GSK names Burberry’s Julie Brown as its new CFO

Daiichi Sankyo grabs first approval for blood cancer drug Ezharmia

11th Annual Pharmaceutical Microbiology Conference

Influencer Marketing and Social Health: Optimizing Pharma’s Impact

8th annual World Cancer Series Europe

single technology appraisal

person touches the water with his hand

Market Access/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Can managed access agreements help unlock access through the NICE Highly Specialised Technology Appraisal Process?

louise.bellamy@pharmaphorum.com HST appraisals, Managed Access Agreement, NICE, single technology appraisal 0 Comment

The National Institute for Health and Care Excellence (NICE) process for single technology appraisals (STA) has been established

X

Can managed access agreements help unlock access through the NICE Highly Specialised Technology Appraisal Process?

https://pharmaphorum.com/market-access-2/can-managed-access-agreements-help-unlock-access-through-the-nice-highly-specialised-technology-appraisal-process/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

GSK names Burberry's Julie Brown as its new CFO
Pfizer, Sangamo resume haemophilia gene therapy trial
Daiichi Sankyo grabs first approval for blood cancer drug Ezharmia
Better Therapeutics files for FDA approval of diabetes DTx
Astellas facing generics to big-selling Lexiscan product in US

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com